Requires health insurers to cover Lyme disease.

This bill (S 926) requires all health insurance plans sold in New Jersey - including hospital service contracts, individual policies, group plans, and health maintenance organizations - to cover medically necessary Lyme disease treatment. It mandates coverage based on a physician's written evaluation of a patient's symptoms and response to treatment, prohibiting insurers from denying coverage solely because treatment is labeled "experimental." The law applies to all relevant insurance contracts issued or renewed in New Jersey after the bill's effective date. It directly affects health insurers and policyholders by ensuring consistent access to Lyme disease care without coverage barriers.